{"name":"John Mascarenhas","slug":"john-mascarenhas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQUEtPeXhaRFFUczIzOElfZFNGRTFYZ21Xa3dNVGkwQ2Ntc2ZRSzZ6NzBKMFBFalRvcHZJQTZta1g3SDczOEZnX1IxVTBIU2ZxNXlnMTgyenRXUHJNN0pnck5PZkVOQ18xX2tEcl95eE5tQ25udTA1TFgwZXhFa3o5UHRfMWxNdmphSzQ0WFBTd014NkhHMFdWaTlwYlZnbzlzMkZ2eNIBowFBVV95cUxQRFNBUzBibDFkNExkZmUyS3BQWmZ6SVZXcGxOTFZQUFdJZS1BWHlvaGV3Z1pJVzRNcmNoSkxLeVhsanZHM001bi0yMDJuOTd4Zkk3WEViMHpWMHhLN2tUTklVbkV3YlNvZ3NNZ2lMMjBoeE5ZZFZ1blhpcjJLdEUxZV9uMXg3cUlfSWZqTnIzekMwQkhta3ZMVU5LUHRlcnB4UFFR?oc=5","date":"2025-10-23","type":"regulatory","source":"ucanews.com","summary":"Japanese cardinal: ‘Can't approve’ over-the-counter morning-after pill - ucanews.com","headline":"Japanese cardinal: ‘Can't approve’ over-the-counter morning-after pill","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMzZLSUVEOXAwQXdOdXdYd1Z6UVJqYVgwV3paTW5peXhCQTRUaXZoNmFvdHdDRzlLSUZUTmhlMnBLYmx6aG9MaXBiOFcyUkNwa3dzcEluajlrZWtZbVkwejhwbTJBRE8ycGc4U0VPaXpnUVBqWXdVN19KdFZYNm1velppRkF0dklPMEYtNTVtd281MkpwcmFjcHI0U3hWVERXTkRRWjFEbE1XY2xxVGc?oc=5","date":"2025-09-30","type":"pipeline","source":"OncLive","summary":"Dr Mascarenhas on the Role of Imetelstat in the Myelofibrosis Treatment Paradigm - OncLive","headline":"Dr Mascarenhas on the Role of Imetelstat in the Myelofibrosis Treatment Paradigm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE50RVIzN1NMUUJmM2l3cUdIVy11R0dNZzJkQWJ6VmI5MTA5TGxhc1hCcVZRUUo4WGdnaGNBR1E0SlQ0SHVBeXJQc3JYeVNZanhsZ2xR?oc=5","date":"2025-06-15","type":"trial","source":"FirstWord Pharma","summary":"EHA25: Incyte unveils early data for mutCALR antibody as Jakafi patent cliff nears - FirstWord Pharma","headline":"EHA25: Incyte unveils early data for mutCALR antibody as Jakafi patent cliff nears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOU3dldFY3YkNoUWxoTUQ0NnJDQW1kWVk2MjJqOTk4ZkVET2xJZ1h3cVEwVU41VmlqSC15SlBiSUlpTXdxZkdfUTJzMFNWS1AyYzUySi15U0RBczNpdDZCX2dPc29Xc1BTaXQ2RVN1d1dDMWtQZUstRjdtUnl4Rjh5aS1tT2hxUQ?oc=5","date":"2023-11-21","type":"pipeline","source":"pharmaphorum","summary":"MorphoSys shrugs off mixed results for myelofibrosis drug - pharmaphorum","headline":"MorphoSys shrugs off mixed results for myelofibrosis drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}